trending Market Intelligence /marketintelligence/en/news-insights/trending/vb_uxzjtxkrihvtz1zgg2g2 content esgSubNav
In This List

Shire increases maximum tender offer for Baxalta debt to $2.33B

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Shire increases maximum tender offer for Baxalta debt to $2.33B

Shire PLC said it increased the maximum tender amount of certain outstanding senior notes of its unit Baxalta to $2.33 billion from $2.25 billion.

Illinois-based Baxalta, Shire's wholly owned subsidiary, develops products for hemophilia, immunology and oncology.

Other terms and conditions for the tender offer remain unchanged, the Dublin-based biotechnology company said.

Citigroup Global Markets Ltd. and Morgan Stanley & Co. LLC are acting as dealer managers, with Global Bondholder Services Corp. acting as depository and information agent.